ID
39785
Descrizione
Study ID: 110399 Clinical Study ID: 110399 Study Title: A randomized, double blind, parallel group, placebo controlled 28 day study to investigate the safety, tolerability and pharmacodynamics of SB-656933 in subjects with cystic fibrosis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00903201 https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB656933, Placebo Trade Name: N/A Study Indication: Cystic Fibrosis The study consists of a screening, five study visits and a follow-up (time relative to Baseline in days): Visit 1: Screening, Day -28 to -16 Visit 2a: Day -7 to -4 Visit 2b: Day 1 Visit 3: Day 14 Visit 4: Day 21 Visit 5: Day 28 Visit 6: Early Withdrawal/ Follow-up, Day 35 to 42. From day 1 to day 28 the patients will receive daily doses. This document contains the Non-serious adverse event form. It has to be filled in if a non-serious AE occurs during the study.
collegamento
https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201
Keywords
versioni (1)
- 19/02/20 19/02/20 -
Titolare del copyright
GlaxoSmithKline
Caricato su
19 febbraio 2020
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Safety, tolerability and pharmacodynamics of Elubrixin in cystic fibrosis patients, NCT00903201
Non-Serious Adverse Events (AE)
- StudyEvent: ODM
Descrizione
Non-serious Adverse Event
Alias
- UMLS CUI-1
- C1518404
Descrizione
In the original form this item is hidden.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C2348184
- UMLS CUI [1,2]
- C0877248
Descrizione
Diagnosis Only (if known) Otherwise Sign/Symptom. Definition of AE: An AE is any untoward medical occurrence in a patient or clinical investigation subject, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. Note: An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a medicinal product. Events meeting the definition of an AE include: -Any abnormal laboratory test results (hematology, clinical chemistry, or urinalysis) or other safety assessments (e.g., ECGs, radiological scans, vital signs measurements), including those that worsen from baseline, and felt to be clinically significant in the medical and scientific judgement of the investigator. -Exacerbation of a chronic or intermittent pre-existing condition including either an increase in frequency and/or intensity of the condition. -New conditions detected or diagnosed after investigational product administration even though it may have been present prior to the start of the study. -Signs, symptoms, or the clinical sequelae of a suspected interaction. -Signs, symptoms, or the clinical sequelae of a suspected overdose of either investigational product or a concomitant medication (overdose per se will not be reported as an AE/SAE). Events that do not meet the definition of an AE include: -Any clinically significant abnormal laboratory findings or other abnormal safety assessments that are associated with the underlying disease, unless judged by the investigator to be more severe than expected for the subject’s condition. -The disease/disorder being studied, or expected progression, signs, or symptoms of the disease/disorder being studied, unless more severe than expected for the subject’s condition. -Medical or surgical procedure (e.g., endoscopy, appendectomy); the condition that leads to the procedure is an AE. -Situations where an untoward medical occurrence did not occur (social and/or convenience admission to a hospital). -Anticipated day-to-day fluctuations of pre-existing disease(s) or condition(s) present or detected at the start of the study that do not worsen.
Tipo di dati
text
Alias
- UMLS CUI [1]
- C1518404
Descrizione
In the original form this item is hidden.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C2826302
- UMLS CUI [1,2]
- C0877248
Descrizione
In the original form this item is hidden.
Tipo di dati
boolean
Alias
- UMLS CUI [1,1]
- C1140263
- UMLS CUI [1,2]
- C0877248
Descrizione
In the original form this item is hidden.
Tipo di dati
boolean
Alias
- UMLS CUI [1,1]
- C3898442
- UMLS CUI [1,2]
- C0877248
Descrizione
In the original form this item is hidden.
Tipo di dati
boolean
Alias
- UMLS CUI [1,1]
- C0805701
- UMLS CUI [1,2]
- C0231175
- UMLS CUI [1,3]
- C0877248
Descrizione
day month year
Tipo di dati
partialDate
Alias
- UMLS CUI [1]
- C2697888
Descrizione
00:00-23:59
Tipo di dati
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C1518404
Descrizione
If you tick "Recovered/Resolved" or "Recovered/Resolved with sequelae", provide End Date and Time
Tipo di dati
integer
Alias
- UMLS CUI [1]
- C1705586
Descrizione
day month year
Tipo di dati
partialDate
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C1518404
Descrizione
00:00-23:59
Tipo di dati
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C1518404
Descrizione
Frequency of AE
Tipo di dati
integer
Alias
- UMLS CUI [1]
- C1518404
Descrizione
Mild: Adverse experience which is easily tolerated Moderate: Adverse experience sufficiently discomforting to interfere with daily activities Severe: Adverse experience which prevents normal everyday activities. An AE that is assessed as severe will not be confused with an SAE. Severity is a category utilized for rating the intensity of an event; and both AEs and SAEs can be assessed as severe.
Tipo di dati
text
Alias
- UMLS CUI [1]
- C1710066
Descrizione
Action Taken with Investigational Product(s) as a Result of the AE
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2826626
Descrizione
Patient withdrawn due to this AE
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1518404
Descrizione
Relationship to Investigational Drug
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0439849
Similar models
Non-Serious Adverse Events (AE)
- StudyEvent: ODM
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])